Buprenorphine Market, By Brand (Sublocade (buprenorphine extended‐release), Suboxone (buprenorphine and naloxone), Brixadi (buprenorphine extended‐release), Zubsolv (buprenorphine and naloxone), and Others (Belbuca, Butrans and among others)), By Type (Branded and Generics), By Route of Administration (Injectable (Intravenous, Intramuscular, Subcutaneous), Sublingual, Buccal, Transdermal, and Others), By Dosage Form (Injectable Solutions, Patches, Films, Others (Tablets, etc.)), By Indication (Opioid Use Disorder (OUD), Pain Management, Acute Pain, Chronic Pain), By Formulation Type (Single Drug Formulation, Fixed Dose Combination), By Age Group (Adults, Pediatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Select a License Type that Suits your Business Needs
US$ 2,200
Two thousand two hundred dollars
Single User License
( Full Report )
US$ 4,500
Four thousand five hundred dollars
Frequently purchased
Multi User License
( Full Report )
US$ 7,000
Seven thousand dollars
Corporate User License
( Full Report )
US$ 10000
Ten thousand dollars
Client Testimonials
Client Testimonials
Our Clients
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

860519526
9001:2015
27001:2022